DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJOR
- 18 February 1984
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 323 (8373), 392-393
- https://doi.org/10.1016/s0140-6736(84)90439-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- EVALUATION OF CARDIAC FUNCTION IN PATIENTS WITH THALASSEMIA MAJORAnnals of the New York Academy of Sciences, 1980
- LONGITUDINAL STUDY OF CARDIAC FUNCTION IN THALASSEMIA MAJOR *Annals of the New York Academy of Sciences, 1980
- Thalassemia Major: Molecular and Clinical AspectsAnnals of Internal Medicine, 1979
- Mechanism of Desferrioxamine‐Induced Iron Excretion in ThalassaemiaBritish Journal of Haematology, 1979
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOADThe Lancet, 1976